Insider · CIK 0001929300

Gilad Oren

Reports to the SEC for 1 company · DOYLESTOWN, PA

sec.gov

Transactions

Companies

Filings

CIK

0001929300

Forms 4 and 5

Insider transactions

25 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-03-12	APREAprea Therapeutics, Inc.A Award	Director, President/CEO	AAward	+20.2K sh	—	—	393,895
2026-03-12	APREAprea Therapeutics, Inc. · Stock Options (Right to Buy)A Award	Director, President/CEO	AAward	+80.7K sh	—	—	80,700
2026-01-30	APREAprea Therapeutics, Inc.P Purchase	Director, President/CEO	PPurchase	+28.1K sh	$0.89	+$25K	373,720
2026-01-30	APREAprea Therapeutics, Inc. · Common WarrantP Purchase	Director, President/CEO	PPurchase	+28.1K sh	—	—	28,100
2025-12-10	APREAprea Therapeutics, Inc. · Pre-Funded WarrantP Purchase	Director, President/CEO	PPurchase	+21.5K sh	$1.17	+$25K	21,459
2025-12-10	APREAprea Therapeutics, Inc. · Common WarrantsP Purchase	Director, President/CEO	PPurchase	+21.5K sh	—	—	21,459
2025-04-03	APREAprea Therapeutics, Inc.P Purchase	Director, President/CEO	PPurchase	+3,003 sh	$1.87	+$5,615.61	343,123
2025-04-03	APREAprea Therapeutics, Inc.P Purchase	Director, President/CEO	PPurchase	+2,497 sh	$1.80	+$4,494.6	345,620
2025-03-27	APREAprea Therapeutics, Inc.A Award	Director, President/CEO	AAward	+6,725 sh	—	—	340,120
2025-03-27	APREAprea Therapeutics, Inc. · Stock Options (Right to Buy)A Award	Director, President/CEO	AAward	+26.9K sh	—	—	26,900
2024-10-23	APREAprea Therapeutics, Inc.P Purchase	Director, President/CEO	PPurchase	+500 sh	$3.92	+$1,957.5	333,395
2024-10-15	APREAprea Therapeutics, Inc.P Purchase	Director, President/CEO	PPurchase	+250 sh	$2.90	+$725	332,895
2024-10-14	APREAprea Therapeutics, Inc.P Purchase	Director, President/CEO	PPurchase	+1,000 sh	$2.59	+$2,590	332,645
2024-10-10	APREAprea Therapeutics, Inc.P Purchase	Director, President/CEO	PPurchase	+150 sh	$2.54	+$381	331,645
2024-03-28	APREAprea Therapeutics, Inc.A Award	Director, President/CEO	AAward	+6,725 sh	—	—	331,495
2024-03-28	APREAprea Therapeutics, Inc. · Stock Options (Right to Buy)A Award	Director, President/CEO	AAward	+26.9K sh	—	—	26,900
2024-03-13	APREAprea Therapeutics, Inc.P Purchase	Director, President/CEO	PPurchase	+2,000 sh	$7.29	+$14.6K	324,770
2024-03-13	APREAprea Therapeutics, Inc. · Tranche A WarrantP Purchase	Director, President/CEO	PPurchase	+1,000 sh	—	—	1,000
2024-03-13	APREAprea Therapeutics, Inc. · Tranche B WarrantP Purchase	Director, President/CEO	PPurchase	+1,000 sh	—	—	1,000
2023-03-09	APREAprea Therapeutics, Inc.A Award	Director, President/CEO	AAward	+4,000 sh	—	—	322,770
2023-03-09	APREAprea Therapeutics, Inc. · Stock Options (Right to Buy)A Award	Director, President/CEO	AAward	+16K sh	—	—	16,000
2022-08-23	APREAprea Therapeutics, Inc.C Conversion	Director, President/CEO	CConversion	+6.05M sh	—	—	6,375,414
2022-08-23	APREAprea Therapeutics, Inc. · Series A Non-Voting Convertible Preferred StockC Conversion	Director, President/CEO	CConversion	−605K sh	—	—	0
2022-07-28	APREAprea Therapeutics, Inc.A Award	Director, President/CEO	AAward	+101K sh	—	—	330,314
2022-07-28	APREAprea Therapeutics, Inc. · Stock Option (right to Buy)A Award	Director, President/CEO	AAward	+149K sh	—	—	148,700

Recent filings

Accepted (ET)
Mar 164
Gilad Oren0001104659-26-028656
SEC(opens sec.gov)
Feb 24
Gilad Oren0001104659-26-009206
SEC(opens sec.gov)
Dec 114
Gilad Oren0001104659-25-120152
SEC(opens sec.gov)
Apr 44
Gilad Oren0001104659-25-031991
SEC(opens sec.gov)
Mar 314
Gilad Oren0001104659-25-029914
SEC(opens sec.gov)
Oct 244
Gilad Oren0001104659-24-111031
SEC(opens sec.gov)
Oct 164
Gilad Oren0001104659-24-108964
SEC(opens sec.gov)
Oct 154
Gilad Oren0001104659-24-108375
SEC(opens sec.gov)
Mar 284
Gilad Oren0001104659-24-040642
SEC(opens sec.gov)
Mar 144
Gilad Oren0001104659-24-034670
SEC(opens sec.gov)
Mar 134
Gilad Oren0001104659-23-031882
SEC(opens sec.gov)

Companies

Aprea Therapeutics, Inc.Director, President/CEOAPRE

Address

3805 OLD EASTON ROAD

DOYLESTOWN, PA, 18902